Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Start Stem Cells is a healthcare provider specializing in regenerative medicine and advanced stem cell therapies, primarily operating out of Puerto Vallarta, Mexico. The company offers a variety of cellular treatments designed to address chronic and degenerative conditions such as chronic obstructive pulmonary disease, multiple sclerosis, and rheumatoid arthritis. Their protocols utilize autologous mesenchymal stem cells derived from the patient's own adipose tissue or bone marrow, as well as allogeneic umbilical cord-derived cells. The facility emphasizes a multidisciplinary approach, combining cell transplantation with supportive therapies to enhance patient outcomes. Start Stem Cells targets an international market, positioning itself as a leading destination for medical tourism in the field of regenerative medicine. The company maintains laboratory facilities that adhere to international standards for cell processing and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Start Stem Cells.